Capping an epic struggle, congressional Democrats put the final touches on historic legislation enshrining health care as the right of every citizen. Republicans vowed to campaign for repeal in the fall election season, drawing a quick retort from President Barack Obama: "I welcome that fight."
ChemImage provides pharmaceutical companies and contract research organizations chemical imaging technology through contract pharmaceutical services.
For more than 60 years, Charles River has helped its global partners accelerate their research and drug development by providing high-quality research models and laboratory animal support expertise.
CTL specializes in T cell immune monitoring (using ELISPOT, ELISA, flow cytometry, etc.), and standardization of procedures, instrumentation and materials.
Discovery-stage ADME-PK services. In vivo studies: Drug disposition in mice, rats and guinea pigs, CSF collection, microdialysis, hepatoportal vein and bile duct-cannulated rats, intraduodenal administration. In vitro: Cell permeability, P-gp substrate/inhibitor determination, Plasma protein binding, Metabolic stability, CYP450 subtypes inhibition/induction, etc.
Particle Sciences is an integrated provider of drug development services. We focus on nano-based drug products, emulsions, gels, particulates and drug/device combination products.
Harlan Laboratories is a leading global provider of essential non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as to academic and government research organizations.
Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization focused on bringing client compounds from discovery to the clinic.
ADPEN provides QC and R&D analytical services, including analyses of biological matrices, analytical support for analytical research, and analysis of active ingredients and marker compounds for QA/QC.
Capsugel's automated CFS 1500 C (Containment) Capsule Filling and Sealing system is available to provide rapid and safe filling and sealing of capsules containing lipid-based formulations or potent compounds for use in early phase clinical trials.
Freeslate, Inc. announced the launch of its third generation Core Module automation system (CM3); designed to optimize workflow integration, it enables scientists to leverage a single automated platform to run a diverse array of laboratory applications.
Celladon Corp. announced that the United States Patent and Trademark Office has granted a notice of allowance for a broad patent covering the company’s lead drug candidate MYDICAR.
Shire plc presented positive data from a Phase 3 clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase.
CCS Cell Culture Service, an international supplier of custom generated recombinant cell lines and custom frozen cells and membranes, has announced the opening of its Princeton, New Jersey laboratory and office space.
Thermo Fisher Scientific Inc. announced that its Biomarker Research Initiatives in Mass Spectrometry Center has extended its collaboration with George Mason University’s Center for Applied Proteomics and Molecular Medicine, Johns Hopkins University, and Toronto’s University Health Network.